New Directions in Glomerular Disease Research, Diagnosis, and Treatment

Pre-Registration is required (please scroll to the bottom)

New Directions in Glomerular Disease Research, Diagnosis, and Treatment
Friday, September 22, 2017
8:00 AM – 5:00 PM
 
Hyatt Regency San Francisco Airport
1333 Old Bayshore Highway
Burlingame, CA 94010
 
Activity Overview 
The symposium is dedicated to knowledge sharing around Nephrotic Syndrome (NS). This CME symposium will help further clinical practice in an area that contains large knowledge and performance gaps. These will be addressed during this conference. This area has few large randomized clinical trials comparing treatments or offering population-based conclusions. Without a forum, a large gap develops between the research and the day to day care of patients. The result is an uneven quality of care and missed opportunities for patients to gain access to new treatments and clinical trials. Sessions will detail the causes and complexities of treating NS patients, the wide variations of patient reactions to treatment, prevention strategies, and the optimal management of care. Expert faculty will present the most current research issues and practice recommendations to support clinicians and providers in the care of patients with NS.

Target Audience
  • Physicians
  • Physician Assistants
  • Other allied health professionals
  • Patient families

Agenda
Course Directors           Paul Brakeman, MD, PhD




 
University of California San Francisco (UCSF) Benioff Children's Hospital


Richard Lafayette, MD, FACP

Stanford University
 
 

8:00 – 9:00 AM


Registration and Breakfast


9:00 – 9:10 AM


Welcome and Introductions
9:10 – 9:55 AM  


Novel Approaches to Therapy Based on Mechanisms of Disease (Targeting Individual Pathways)
Richard Lafayette, MD, FACP

Stanford University
9:55 – 10:40 AM
At the conclusion of the activity, participants will be better able to:       - Explain mechanisms of disease and the meaning of targeting        individual pathways.






Epidemiology of Glomerular Disease: The Devil is in the Data
Michelle O'Shaughnessy, MBBCh, MS
Stanford University

 
 

At the conclusion of the activity, participants will be better able to:       - Recognize the epidemiology of Nephrotic Syndrome (NS) and        Focal Segmental Glomerulosclerosis (FSGS).


10:40 – 10:50 AM Refreshment Break
10:50 – 11:35 AM








Steroid Sparing Agents in Pediatric Steroid Sensitive Nephrotic Syndrome
Gia Oh, MD
Stanford University


 

At the conclusion of the activity, participants will be better able to:       - Recall best practice strategies to help family members ensure        that patients remain compliant with treatment.
11:35 AM – 12:20 PM

 





 
Defining and Achieving Success in Glomerular Disease Patient Health Outcomes

Debbie Gipson, MD, MS
University of Michigan
NephCure Accelerating Cures Institute (NACI)


 

At the conclusion of the activity, participants will be better able to:       - Identify how patient trials lead to better treatment outcomes.


 
12:20 – 1:20 PM Lunch

 
1:20 – 2:00 PM Patient Panel
2:00 – 2:45 PM






Why We Care about Podocytes in FSGS and Minimal Change Disease
Stuart  J. Shankland, MD, MBA, FRCP
University of Washington

At the conclusion of the activity, participants will be better able to:       - Review the podocyte in NS patients to achieve better care              outcomes.
2:45 – 3:30 PM

What We Can Learn from the Genetics of FSGS
Paul Brakeman, MD, PhD
University of California, San Francisco Benioff Children's Hospital
3:30 – 4:15 PM  

At the conclusion of the activity, participants will be better able to:       - Articulate the role genetics play in Nephrotic Syndrome.





Recurrence of Glomerular Disease Post Transplant: Current Management and Novel Therapies
Allison Webber, MD
University of California San Francisco


 

At the conclusion of the activity, participants will be better able to:       - Discuss how post-transplant glomerular disease guides us for        therapies and improves late outcomes

4:15 – 5:00 PM
 








How Does Renal Pathology Guide Clinical Practice?
Kevin V.  Lemley, MD, PhD.
University of Southern California
Children's Hospital Los Angeles


 

At the conclusion of the activity, participants will be better able to:       - Discuss how renal pathology guides patient care.


5:00 PM                            Closing Remarks


Planning Committee

Paul Brakeman, MD, PhD
University of California San Francisco (UCSF) Benioff Children's Hospital

Richard Lafayette, MD, FACP
Stanford University

Lauren Lee
NephCure Kidney International

Rebecca Cook
NephCure Kidney International

Nathalie Harden
National Kidney Foundation


Accreditation/Designation of Credit Information

This activity has been planned and implemented by NephCure® Kidney International and The National Kidney Foundation. The National Kidney Foundation is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME), to provide continuing education for the healthcare team.
 
Physicians 
The National Kidney Foundation designates this live activity for a maximum of 6.0 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Physician Assistants
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit(s)™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 6.0 hours of Category I credit for completing this program.

Declaration of Disclosure
It is the policy of the National Kidney Foundation (NKF) to ensure balance, independence, objectivity, and scientific rigor in all CME/CE activities. Any individual who has control over CME/CE content is required to disclose to learners prior to the activity any relevant financial relationship(s) they may have with commercial interests supporting this activity or whose products or devices are discussed in this activity.

If, on the basis of information disclosed, a perceived conflict exists, resolution will be achieved based on NKF's Disclosure and Conflict of Interest Policy.

Unlabeled/Investigational Use 
During their presentations, faculty may discuss an unlabeled use or an investigational use not approved for a commercial product. Each faculty member is required to disclose this information to the audience when referring to an unlabeled or investigational use.

Disclaimer
The faculty and National Kidney Foundation (NKF) do not recommend the use of any pharmaceutical, diagnostic test, or device outside of the labeled indications as approved by the FDA. Please refer to the official prescribing information for each product for approved indications, contraindications, and warnings.

Information contained in this NKF educational resource is based upon current data available at the time of publication. Information is intended to help clinicians become aware of new scientific findings and developments. This NKF educational resource is not intended to set out a preferred standard of care and should not be construed as one. Neither should the information be interpreted as prescribing an exclusive course of management.

Variations in practice will inevitably and appropriately occur when clinicians take into account the needs of individual patients, available resources, and limitations unique to an institution or type of practice. Every healthcare professional making use of information in this NKF educational resource is responsible for interpreting the data as it pertains to clinical decision making in each individual patient.

Acknowledgement of Sponsors 

The National Kidney Foundation and NephCure Kidney International gratefully acknowledge Retrophin, Inc. as a sponsor of this activity.


Please contact Rebecca Cook at rcook@nephcure.org for more information about this event.


Registration Information

Patients/Patient Family Registration

$0

Physician Registration

$50

Other Allied Health Professionals

$25

Residents/Fellows/Students

$0

Speaker

$0

Sponsor/Exhibitor

$0

Industry Professional

$0
Total: $0.00

Your Information